Skip to main content
. 2020 Dec 28;48(6):1876–1889. doi: 10.1007/s00259-020-05162-6

Table 3.

Diagnostic accuracy of [18F]FDG-PET/CT findings

Site positive on [18F]FDG-PET/CT No. of patients (no. of cohortsb) Sensitivity (95% CI) Specificity (95% CI) Diagnostic OR (95% CI) LR+ (95% CI) LR− (95% CI)
Hip 346 (5) 63.7 (46.3–78.1) 78.1 (69.1–85.1) 6.25 (3.32–11.79) 2.91 (2.09–4.05) 0.47 (0.31–0.70)
Greater trochanter 428 (6) 83.3 (59.0–94.5) 56.7 (38.3–73.5) 6.54 (2.87–14.90) 1.93 (1.43–2.59) 0.29 (0.13–0.66)
Interspinous bursa 546 (6) 74.5 (59.3–85.4) 81.4 (59.6–92.8) 12.76 (5.64–28.89) 4.00 (1.84–8.71) 0.31 (0.21–0.47)
Ischial tuberosity 428 (6) 85.4 (62.3–95.4) 70.1 (53.5–82.7) 13.72 (5.20–36.18) 2.86 (1.91–4.28) 0.21 (0.08–0.54)
Shouldera 406 (6) 78.4 (65.4–87.5) 69.5 (42.5–87.5) 8.30 (3.05–22.58) 2.57 (1.24–5.32) 0.31 (0.19–0.49)
Sternoclavicular joint 375 (5) 64.4 (39.1–83.6) 72.1 (48.3–87.8) 4.68 (2.06–10.63) 2.31 (1.33–4.02) 0.49 (0.29–0.83)

Hierarchical logistic regression modelling was used to determine summary estimates of the sensitivity, specificity, diagnostic odds ratio and likelihood ratios by the bivariate model approach. 95% CI 95% confidence interval, OR odds ratio, LR+ positive likelihood ratio, LR− negative likelihood ratio

aData either reported as shoulder or glenohumeral joint

bIn case of potential data overlap between studies, only data from one study was used according to criteria described in the “Methods” section